In medication use and improving patient outcomes, Susan Cooper, MPH, RPh, senior director, pharmacy services, HealthPartners, says her organization envisions prescription drug optimization going beyond addressing adherence. It seeks to improve the patient experience.
In medication use and improving patient outcomes, Susan Cooper, MPH, RPh, senior director, pharmacy services, HealthPartners, says her organization envisions prescription drug optimization going beyond addressing adherence. It seeks to improve the patient experience. Dr Cooper suggests that efficient optimization can underline the triple aim (quality, experience, and affordability) through successful integration approaches, including those that use technology.
Addressing underuse, overuse, and misuse of medications is important because nearly half of the current population do not currently adhere properly to medication. The reasons behind nonadherence vary—Dr Cooper says that it is easy to find thousands of studies that address the reasons, but “The bottom line is that there is no silver bullet or no 1 reason why people aren’t taking their medications.”
Things can go wrong in optimizing medication adherence at many stages, including during diagnosis or treatment (eg, a patient might not arrive for an appointment), with prescriptions (eg, wrong dose or wrong medication), or in continuation and following up (eg, a patient stops taking medication).
In assessing how to focus the optimization of medication, Dr Cooper highlighted the results of a predictive algorithm that uses integrated data sources to identify and stratify high-risk members to targeted interventions based on assessed need. This includes:
The predictive modeling approach includes coding, analysis, interpretation, recommendations, intervention and trials, optimization, and performance analysis. Patient-centered contact technology can be used to identify patients and customize messaging to patients based on their needs. HealthPartners looks at the data and how they can learn from them to promote health behavior.
“Medication therapy management (MTM) pharmacists work to ensure that patients’ medications are appropriate,” she said. “HealthPartners’s MTMs are delivered through existing relationships and integrated within care teams whenever possible.”
Dr Cooper added that MTMs “want to be as integrated as possible.”
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More